Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06144554 · ClinicalTrials.gov registry record
Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
A clinical trial of Type 1 Diabetes, sponsored by Insulet Corporation.
- Recruiting
- Registry status
- 2,200
- Enrollment target
- 1
- Study location
NCT06144554: Recruiting study of Type 1 Diabetes, sponsored by Insulet Corporation.
NCT06144554 is a study of Type 1 Diabetes that is actively recruiting participants, run by Insulet Corporation. The registered enrollment target is 2,200 participants, above the 756-participant average among 198 other Type 1 Diabetes trials with a reported enrollment target (191% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06144554, a study of Type 1 Diabetes, is actively recruiting participants, sponsored by Insulet Corporation.
- RECRUITING
- Registry status
- 2,200 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a decentralized observational clinical registry to collect real-world evidence related to the safety and effectiveness of the Omnipod 5 system in children and adults with Type 1 Diabetes.
Primary Outcome
Measures frequency of severe hypoglycemia
Conditions Studied
Interventions
- DEVICE Omnipod 5
Study Locations (1)
New York
- Circuit Clinical - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,200 participants |
| Start Date | 2023-09-25 |
| Est. Completion | 2027-09 |
What NCT06144554 shows while recruiting
NCT06144554 is an observational study that tracks outcomes without assigning an intervention. Its 2,200 participants enrollment target places it among the larger protocols in the corpus, above the 756-participant average among 198 other Type 1 Diabetes trials with a reported enrollment target (191% higher).
The record links to 1 condition, with Type 1 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Omnipod 5 is the first listed.
NCT06144554 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06144554 about?
NCT06144554 is a clinical study titled "Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes". This is a decentralized observational clinical registry to collect real-world evidence related to the safety and effectiveness of the Omnipod 5 system in children and adults with Type 1 Diabetes.
What is the current status of trial NCT06144554?
This trial is currently recruiting. The enrollment target is 2,200 participants. The study started on 2023-09-25. Estimated completion is 2027-09.
What conditions does trial NCT06144554 study?
This clinical trial studies the following conditions: Type 1 Diabetes.
What interventions are being tested in trial NCT06144554?
The interventions under investigation include: Omnipod 5 (DEVICE).
Who is sponsoring clinical trial NCT06144554?
This trial is sponsored by Insulet Corporation, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06144554 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 1 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06144554's enrollment target sits among peer trials
2,200 7th of 198 higher than 192 of 198 other Type 1 Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 1 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
RECRUITING · Phase 1
-
Multivariable Artificial Pancreas: Detecting and Mitigating Unannounced Physical Activity and Acute Psychological Stress
RECRUITING
-
Extended Bolus for Meals in a Closed-loop System
RECRUITING · Phase 4
-
REAL-Fam Feasibility Study for Youth Diabetes Management
RECRUITING · NA
-
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
RECRUITING · Phase 1
-
AIDANET Pediatrics
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05654207 · 2,200 participants · NA
WeCare: A System of Care for Black Youth
- NCT06526988 · 2,200 participants · NA
Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure
- NCT06682650 · 2,200 participants · NA
Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)
- NCT06828406 · 2,200 participants · NA
Improving Safety, Patient Experience and Equity Through Shared Decision-making Huddles in Labor
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI